Skip to content

Lung Surgery With Enhanced Recovery VS. Lung Surgery Without Enhanced Recovery

The Short Term and Long Term Comparison of Lung Surgery With or Without Enhanced Recovery

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04451473
Enrollment
350
Registered
2020-06-30
Start date
2019-10-08
Completion date
2027-06-30
Last updated
2022-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ERAS, Lung Cancer, Surgery

Brief summary

Objective: The adoption of Enhanced Recovery Surgery programs in lung resection is relatively recent with limited outcome data. This study aimed to determine the impact of an Enhanced Recovery Surgery pathway on short- term and long- term results in patients undergoing lung resection for primary lung cancer. Methods: A Randomized Controlled Trial was designed to collect the perioperative data on consecutive patients undergoing lung resection for primary lung cancer. Patients will be randomizely assigned to the ERAS- Group and Control- Group. Short-term and long- term effect will be compared between the two groups.

Interventions

PROCEDUREEnhanced Recovery After Surgery (ERAS )

the treatment of procedure according to Guidelines for enhanced recovery after lung surgery: recommendations of the ERAS Society and the ESTS

PROCEDURETraditional perioperative management without Enhanced Recovery After Surgery (ERAS )

the treatment of procedure not abiding Guidelines for enhanced recovery after lung surgery

Sponsors

The Second Hospital of Shandong University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

patients with stage I-IIIa Non-small-cell Lung Cancer underwent radical resection or other benign lung lesions need VATS surgery. \-

Exclusion criteria

cardio-pulmonary function couldn't tolerate surgery \-

Design outcomes

Primary

MeasureTime frameDescription
complicationswithin 7 days after surgerythe rate of complications
the time for oral feedwithin 48 hours after surgerythe time for oral feed
the time of hospitalizationwithin 5 days after surgerythe time of hospitalization
intensive care unit utilizationwithin 4 days after surgerythe time in intensive care unit utilization
the degree of painwithin 4 days after surgeryVisual Analogue Scale/Score
the time of ambulationwithin 48 hours after surgerythe time after surgery that patients could leave the bed and walk

Secondary

MeasureTime frameDescription
overall survivalwithin 10 years after surgeryoverall survival
disease- free survivalwithin 5 years after surgerydisease- free survival

Countries

China

Contacts

Primary ContactYunpeng Zhao, Doctor
zhaoyunpengsddx@sdu.edu.cn17660081916

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026